Harrow (HROW) Shares Outstanding (Weighted Average) (2010 - 2026)
Harrow (HROW) recorded quarterly Shares Outstanding (Weighted Average) of $37.2 million in Q1 2026, up 1.28% quarter-over-quarter from $36.8 million in Q4 2025, and up 3.92% on a YoY basis from $35.8 million in Q1 2025.
Harrow (HROW) Shares Outstanding (Weighted Average) (2010 - 2026) Analysis & Trends
Harrow's Shares Outstanding (Weighted Average) history runs 17 years deep, the most recent figure standing at $37.2 million for Q1 2026.
- In Q1 2026, Shares Outstanding (Weighted Average) rose 3.92% year-over-year to $37.2 million; the TTM figure through Mar 2026 stood at $37.2 million (up 3.92% YoY), while the FY2025 annual figure was $36.8 million, up 3.11% from the prior year.
- Shares Outstanding (Weighted Average) was $37.2 million for Q1 2026 at Harrow, up from $36.8 million in the prior quarter.
- In the past five years, Shares Outstanding (Weighted Average) ranged from a high of $37.2 million in Q1 2026 to a low of $27.2 million in Q1 2022.
- Historically, Shares Outstanding (Weighted Average) has averaged $33.1 million across 5 years, with a median of $35.5 million in 2024.
- The sharpest annual moves came in 2023 and 2025: Shares Outstanding (Weighted Average) advanced 25.51% in 2023, then rose 1.01% in 2025.
- A 5-year view of Shares Outstanding (Weighted Average) shows it stood at $27.5 million in 2022, then increased by 18.78% to $32.6 million in 2023, then advanced by 9.3% to $35.7 million in 2024, then grew by 3.11% to $36.8 million in 2025, then rose by 1.28% to $37.2 million in 2026.
- The last three Shares Outstanding (Weighted Average) figures came in at $37.2 million (Q1 2026), $36.8 million (Q4 2025), and $37.1 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares (Weighted Avg.) (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 38.34 Bn | 34.60 Bn | 1.97 Bn | 1.16 Bn |
| 2 | Zoetis | 33.27 Bn | 31.33 Bn | 1.62 Bn | 422.10 Mn |
| 3 | United Therapeutics | 23.75 Bn | 21.60 Bn | 648.10 Mn | 43.50 Mn |
| 4 | Aurora Cannabis | 17.11 Bn | 17.03 Bn | 33.43 Mn | 5.02 Bn |
| 5 | Neurocrine Biosciences | 16.37 Bn | 15.05 Bn | 800.70 Mn | 100.50 Mn |
| 6 | Elanco Animal Health | 11.78 Bn | 11.35 Bn | 785.00 Mn | 497.70 Mn |
| 7 | Alkermes | 7.05 Bn | 6.54 Bn | -116.06 Mn | 166.20 Mn |
| 8 | Lantheus Holdings | 6.49 Bn | 5.99 Bn | 230.92 Mn | 64.74 Mn |
| 9 | Hims & Hers Health | 6.19 Bn | 5.44 Bn | 396.79 Mn | 228.36 Mn |
| 10 | Harrow | 1.23 Bn | 1.14 Bn | 27.05 Mn | 37.23 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 37.23 Mn |
| Dec 31, 2025 | 36.76 Mn |
| Sep 30, 2025 | 37.15 Mn |
| Jun 30, 2025 | 36.30 Mn |
| Mar 31, 2025 | 35.83 Mn |
| Dec 31, 2024 | 35.65 Mn |
| Sep 30, 2024 | 35.60 Mn |
| Jun 30, 2024 | 35.54 Mn |
| Mar 31, 2024 | 35.47 Mn |
| Dec 31, 2023 | 32.62 Mn |
| Sep 30, 2023 | 34.26 Mn |
| Jun 30, 2023 | 30.38 Mn |
| Mar 31, 2023 | 30.29 Mn |
| Dec 31, 2022 | 27.46 Mn |
| Sep 30, 2022 | 27.29 Mn |
| Jun 30, 2022 | 27.30 Mn |
| Mar 31, 2022 | 27.23 Mn |
| Dec 31, 2021 | 26.76 Mn |
| Sep 30, 2021 | 26.63 Mn |
| Jun 30, 2021 | 26.74 Mn |